Mackenzie Financial’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $444K | Buy |
4,125
+372
| +10% | +$40K | ﹤0.01% | 1266 |
|
|
2025
Q1 | $335K | Sell |
3,753
-150
| -4% | -$13.4K | ﹤0.01% | 1343 |
|
|
2024
Q4 | $445K | Sell |
3,903
-19,370
| -83% | -$2.21M | ﹤0.01% | 1225 |
|
|
2024
Q3 | $2.74M | Buy |
23,273
+6,207
| +36% | +$732K | ﹤0.01% | 660 |
|
|
2024
Q2 | $1.38M | Sell |
17,066
-13,023
| -43% | -$1.05M | ﹤0.01% | 799 |
|
|
2024
Q1 | $2.78M | Buy |
30,089
+8,215
| +38% | +$760K | ﹤0.01% | 668 |
|
|
2023
Q4 | $2.3M | Buy |
21,874
+16,743
| +326% | +$1.76M | ﹤0.01% | 700 |
|
|
2023
Q3 | $558K | Buy |
5,131
+2,380
| +87% | +$259K | ﹤0.01% | 977 |
|
|
2023
Q2 | $298K | Buy |
2,751
+431
| +19% | +$46.7K | ﹤0.01% | 1171 |
|
|
2023
Q1 | $286K | Sell |
2,320
-6,530
| -74% | -$804K | ﹤0.01% | 1202 |
|
|
2022
Q4 | $1.33M | Buy |
8,850
+691
| +8% | +$104K | ﹤0.01% | 735 |
|
|
2022
Q3 | $1.1M | Buy |
8,159
+3,406
| +72% | +$460K | ﹤0.01% | 799 |
|
|
2022
Q2 | $709K | Buy |
4,753
+3,204
| +207% | +$478K | ﹤0.01% | 890 |
|
|
2022
Q1 | $264K | Sell |
1,549
-1,650
| -52% | -$281K | ﹤0.01% | 1173 |
|
|
2021
Q4 | $825K | Buy |
3,199
+2,137
| +201% | +$551K | ﹤0.01% | 940 |
|
|
2021
Q3 | $290K | Buy |
+1,062
| New | +$290K | ﹤0.01% | 1150 |
|
|
2021
Q1 | – | Sell |
-2,501
| Closed | -$204K | – | 1124 |
|
|
2020
Q4 | $204K | Buy |
+2,501
| New | +$204K | ﹤0.01% | 992 |
|